Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | TP53 | P04637 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24709164 | 0.91 | ALDH1A1 (0.55) | ALDH1A1KMT2ATP53TSHRMAPT | |
| Methacrylic Acid SCHEMBL7570281 | 0.89 | ALDH1A1 (0.74) | ALDH1A1KMT2ATP53TSHRMAPT | |
| Methacrylic Acid SCHEMBL8741404 | 0.89 | ALDH1A1 (0.74) | ALDH1A1KMT2ATP53TSHRMAPT | |
| SCHEMBL7603742 | 0.87 | ALDH1A1 (0.51) | ALDH1A1KMT2ATP53TSHRMAPT | |
| SCHEMBL4403982 | 0.87 | ALDH1A1 (0.51) | ALDH1A1KMT2ATP53TSHRMAPT | |
| SCHEMBL7661052 | 0.87 | ALDH1A1 (0.64) | ALDH1A1KMT2ATP53TSHRMAPT | |
| SCHEMBL7923720 | 0.87 | KMT2A (0.50) | ALDH1A1KMT2ATP53TSHRMAPT | |
| SCHEMBL12520495 | 0.86 | ALDH1A1 (0.62) | ALDH1A1KMT2ATP53TSHRMAPT | |
| SCHEMBL13383361 | 0.86 | ALDH1A1 (0.62) | ALDH1A1KMT2ATP53TSHRMAPT | |
| Methacrylic Acid SCHEMBL3864596 | 0.84 | KMT2A (0.47) | ALDH1A1KMT2ATP53TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6194511-B1 | COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2001-02-27 | — | — | US | claimed |
| US-5776376-A | BLEND OF EPOXY AND UNSATURATED ESTER MONOMERS | TOKUYAMA CORPORATION (JP) | 1998-07-07 | — | — | US | claimed |
| EP-4399274-A1 | METHOD OF HARVESTING BIOLOGICS | Solventum Intellectual Properties Company (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240131450-A1 | CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-04-25 | — | — | US | disclosed |
| EP-4297884-A1 | CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS | 3M Innovative Properties Company (US) | 2024-01-03 | — | — | EP | disclosed |
| US-20230323151-A1 | IMIDE ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2023-10-12 | — | — | US | disclosed |
| US-20230227496-A1 | FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-07-20 | — | — | US | disclosed |
| WO-2023105315-A1 | DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023105327-A1 | ADHESIVES COMPRISING CYCLIC IMIDE ADDITION-FRAGMENTATION AND ADHESION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023037178-A1 | METHOD OF HARVESTING BIOLOGICS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-03-16 | — | — | WO | disclosed |
| EP-4136093-A1 | FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE | 3M Innovative Properties Company (US) | 2023-02-22 | — | — | EP | disclosed |
| US-5708063-A | REVERSABLE COLOR COMPOUNDS | TOKUYAMA CORPORATION (JP) | 1998-01-13 | — | — | US | disclosed |
| EP-0778276-A1 | Photochromic chromene derivatives | TOKUYAMA CORPORATION (JP) | 1997-06-11 | — | — | EP | disclosed |
| US-5631382-A | PHOTOCHROMIC LENSES | TOKUYAMA CORPORATION (JP) | 1997-05-20 | — | — | US | disclosed |
| EP-0773273-A1 | PROCESS FOR THE PRODUCTION OF PHOTOCHROMIC PRODUCT OF CURING | TOKUYAMA CORPORATION (JP) | 1997-05-14 | — | — | EP | disclosed |
| EP-0773272-A1 | PHOTOCHROMIC CURABLE COMPOSITION | TOKUYAMA CORPORATION (JP) | 1997-05-14 | — | — | EP | disclosed |
| US-5621017-A | PHOTOCHROMIC COMPOSITION INCLUDING RADICAL POLYMERIZABLE MONOMER, CHROMENE AND/OR SPIROOXAZINE BASED PHOTOCHROMIC COMPOUND, PHOTOPOLYMERIZATION INITIATOR | TOKUYAMA CORPORATION (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0696582-A1 | Polycyclic spirophthalimide derivatives, process for their preparation and their use as fulgimides | TOKUYAMA CORPORATION (JP) | 1996-02-14 | — | — | EP | disclosed |
| EP-0681018-A2 | Photochromic composition and method of producing photochromic cured product | TOKUYAMA CORPORATION (JP) | 1995-11-08 | — | — | EP | disclosed |
| EP-0629626-A2 | Cyclopropyl-substituted spiro-photochromic compounds | TOKUYAMA CORPORATION (JP) | 1994-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227496-A1 | FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE | SHBG, SERPINA6, IDE | ALDH1A1 3634/4885KMT2A 3244/4885TP53 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.